Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: dalroi who wrote (8)	7/25/1999 2:20:00 PM
From: Biomaven	Read Replies (2) \| Respond to of 427

Bafort, As far as I know the Adcon rumors are totally without any foundation. However it's very hard to disprove most "plausible" rumors. Once you get a few thousand surgeons using a product I assume there will be a few bad outcomes that likely have nothing to do with the product but still can be used to blacken it. A lot of short attacks seem to come in the period just after a company gets its first product approved and is making the transition to profitability. Given that sales for many new products can take a year or even longer to really get going, it's easy to point to slow sales and continuing losses (or a huge PE ratio) as an argument that a stock is overvalued. Peter